Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

CUSIP: 48576U106

Q1 2017 13F Holders as of 31 Mar 2017

Holder snapshot 7 signals
Share change
+3,428,941
Put/Call ratio
79%
SEC-reported price per share
$12.84
Number of holders
79
Value change
+$45,322,035
Number of buys
43
Open additional details 1 more signal available
Number of sells
35
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
22,658,403

Security key

48576U106

Report period

Q1 2017

Institutions

79

Top holders

10

Ownership snapshot

Top reported holders of KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
31 Dec 2016
13F Lead comparable stake: 25% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 25%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 25%
FMR LLC 21%
FRANKLIN RESOURCES INC 14%
Palo Alto Investors LP 14%
BlackRock Fund Advisors 6.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
25%
$53,828,000
5,726,416 shares
31 Dec 2016
FMR LLC
13F
Company
13F
21%
$44,463,000
4,730,131 shares
31 Dec 2016
FRANKLIN RESOURCES INC
13F
Company
13F
14%
$30,374,000
3,231,201 shares
31 Dec 2016
Palo Alto Investors LP
13F
Company
13F
14%
$30,084,000
3,200,396 shares
31 Dec 2016
BlackRock Fund Advisors
13F
Company
13F
6.1%
$12,938,000
1,376,355 shares
31 Dec 2016
VANGUARD GROUP INC
13F
Company
13F
5%
$10,591,000
1,126,669 shares
31 Dec 2016
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
79
Shares
26,846,913
Rows available
79
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders
85
Q1 2017 holders
79
Holder diff
-6
Investor Q4 2016 Shares Q1 2017 Shares Share Diff Share Chg % Q4 2016 value Q1 2017 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .